ANNAPOLIS, Md. - Marylandian -- METAvivor Research and Support, Inc. announces an engagement conference to help those in the healthcare setting, research and within the patient community to share information about health disparities in metastatic breast cancer (MBC) and to bring healthcare providers, researchers, patients and caregivers together to discuss and develop actionable strategies to overcome these disparities in MBC. The conference will feature thought leaders in the metastatic breast cancer community and will have a unique roundtable discussion to develop key tasks that will lead toward the goal of eliminating disparities.

According to Jamil Rivers, president of METAvivor "We are excited to host this powerful virtual conference that will allow us to leave with actionable strategies to overcome disparities in metastatic breast cancer. We are so thankful to our title sponsor, Astrazenaca and our platinum sponsors Eisai Global and Lilly Oncology for recognizing the importance of this topic and helping METAvivor make this conference a reality."

More on Marylandian

• Maryland: Poultry Farmers Urged to Practice Enhanced Biosecurity
• Governor Moore Signs Executive Order Establishing the Maryland Horse Industry Strategic Plan
• Local Lighting Experts Debut AI Christmas Decorator: Upload a Photo, Get Instant Professional Holiday Design-- Completely Free
• Surf Air Mobility (N Y S E: SRFM) Accelerates Regional Air Mobility Revolution with Electra Aero Partnership, Palantir Alliance, and Record Revenue
• Cybersecurity is Fast Becoming a Vital Issue for Protecting Personal Information and Portfolio Wealth

The virtual conference is a two-day, 3.5 hour conference beginning on Friday, September 24 from 5:30 pm EDT and reconvening on Saturday, September 25 at 10:30 am EDT. The event will open with an exhibit hall that includes partners and sponsors of the program. For more information or to register, go to https://pheedloop.com/METAvivor/site/home/

About Metastatic Breast Cancer
Metastatic breast cancer also known as stage IV or advanced breast cancer, occurs when the cancer has spread from the breast to other parts of the body.  This usually includes the lungs, liver, bones or brain. 115 women and men die each day from metastatic breast cancer. There is no cure for metastatic breast cancer. Although there are treatments and therapies for those living with the disease the median life span remains 33 months.

Racial Disparities in Breast Cancer
The overall rate of breast cancer is similar for black and white women, although black women are 42 percent more likely to die from the disease. Other disparities for black women compared with white women include a higher rate of breast cancer before age 40, a greater likelihood of being diagnosed at a late stage and an increased risk of having triple-negative breast cancer, which tends to be more aggressive.

More on Marylandian

• 10 Essential Tips for Maximizing Value When Choosing Your Orlando Wedding Venue
• Americans Are Trading Offices for Beaches: How Business Ownership Enables the Ultimate Location Freedom
• Boston Industrial Solutions' Natron® DC Series Ink Has Had an Upgrade!
• Colony Ridge Proudly Supports the All Ears! 2025 Sporting Clays Tournament
• Jacob Emrani Nominated for LA Executive Award

About METAvivor
METAvivor Research and Support Inc.  is a non-profit organization with a primary mission to fund critical research that will lead to advances in treatment options, improve quality of life and survival for patients diagnosed with metastatic breast cancer.  METAvivor has awarded 135 research grants totaling over $18 million. METAvivor is the only national organization with a peer-reviewed grant program aimed at exclusively funding MBC research, and 100% of all donations go to fund research.

METAvivor also raises awareness of MBC, provides support for people living with the terminal disease, and offers opportunities for others to help make a difference for the metastatic community. METAvivor has gained a rapidly growing following within the breast cancer community and has become a leader in in metastatic breast cancer research.